explore -WSS

explore

author：Wikipedia 2025-09-14 10:04:40 - browse：2411

Stock illustration of computer and medication — Adobe

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

“My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： With psoriasis trial ahead, Alumis raises $259 million

entertainment

WSS

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

UnitedHealth quietly bought dozens of outpatient centers

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

WHO recommends second malaria vaccine

Experts study whether long Covid risk adds up with each reinfection

Former medical device CEO who sold dummy, plastic parts convicted of fraud

focus

explore

hotspot

Cancer drug shortages should be causing more outrage

Amylyx ALS drug failure raises questions and concerns

DIEP, the 'gold standard' of breast reconstruction, is under threat

Just how do doctors, lawmakers, and the public define abortion?

How one medical school became remarkably diverse

The Karikó problem: Lessons for funding basic research

DIEP, the 'gold standard' of breast reconstruction, is under threat

Some top drug companies are starting to take action on climate

What does generative AI mean for health care? We asked experts

First medicine developed to treat MASH expected to be approved soon

knowledge

Amylyx ALS drug failure raises questions and concerns

What will Novo Nordisk's VC do with its influx of cash?

What it’s like to watch children die of measles

Will an HIV vaccine ever be a reality?

RSV injection headlines need to be accurate for good uptake

Experts study whether long Covid risk adds up with each reinfection

Wikipedia

knowledge

entertainment

explore